Revenue $63.67B, up 5.8% on a year earlier. Global Medical Products and Distribution Revenue $3.13B, down 2.2%. Pharmaceutical and Specialty Solutions Revenue $58.85B, up 6.3%.
| Q4 FY26 | Q3 FY26 | Q4 FY25 | Year over year | |
|---|---|---|---|---|
| Revenue | $63.67B | $60.94B | $60.16B | +5.8% |
| Operating income | $729.00M | $509.00M | $428.00M | +70.3% |
| Capital expenditures | -$264.00M | -$146.00M | -$232.00M |
| Q4 FY26 | Q4 FY25 | Year over year | |
|---|---|---|---|
| Global Medical Products and Distribution Revenue | $3.13B | $3.20B | -2.2% |
| Pharmaceutical and Specialty Solutions Revenue | $58.85B | $55.37B | +6.3% |
| Revenue growth rate | 6% | 3% |
The week's biggest guidance misses, KPI surprises and one chart.
Stock Atlas, “Cardinal Health (CAH) Q4 FY26 earnings: results and KPIs”, stockatlas.com/companies/CAH/earnings/2026-q4/, data as of 3 November 2026. Links to this page are welcome.
